Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

832 recalls, newest first

Class II · Moderate risk

Lisinopril Tablets USP

Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68001-334-08 D-1413-2020
Class II · Moderate risk

Lidocaine Patch 5%

Labeling: Incorrect or Missing Lot and/or Exp date on the individual transdermal pouches but not in the carton.

Terminated Labeling / mix-up Teva Pharmaceuticals USA NDC 0591-3525-30 D-1492-2020
Class III · Low risk

Fosaprepitant for Injection

Labeling Error: Label Error on Declared Strength: Carton label and product insert incorrectly states the quantity of the excipient edetate disodium (EDTA) as 5.4 mg / vial, rather than the actual amount of 18.8 mg / vial.

Terminated Labeling / mix-up Fresenius Kabi USA, LLC NDC 63323-972-10 D-1391-2020
Class II · Moderate risk

blumen ADVANCED HAND SANITIZER

CGMP Deviations: recalled because it was manufactured in the same facility as the product found to contain methanol which represents poor Current Good Manufacturing Practices.

Terminated Chemical / undeclared 4e Brands North America, Llc D-0023-2021
Class II · Moderate risk

Auryxia (ferric citrate)

cGMP deviations: Lots recalled were not manufactured in conformance with the FDA-approved manufacturing process for Auryxia.

Terminated cGMP deviation Keryx Biopharmaceuticals, Inc. D-1389-2020
Class II · Moderate risk

Shine & Clean Hand Sanitizer gel

CGMP Deviations: Products manufactured at the same site were FDA testing found below the label claim for ethanol content and the presence of undeclared methanol.

Terminated Chemical / undeclared Maquiladora Miniara Sa De Cv NDC 76753-001-01 D-1565-2020

Recalls by year